603222.SS - Chimin Health Management Co., Ltd.

Shanghai - Shanghai Delayed Price. Currency in CNY
  • Dividend

    603222.SS announced a cash dividend of 0.02 with an ex-date of Jun. 7, 2023

Chimin Health Management Co., Ltd.

No. 888, Beiyuan Road
Huangyan 318020
China
86 576 8406 6588
https://www.chimin.cn

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees1,851

Key Executives

NameTitlePayExercisedYear Born
Mr. Yunfei TianPres & DirectorN/AN/A1982
Mr. Kun ChenVP, CFO & DirectorN/AN/A1983
Mr. Gao Peng QiuExec. VP & DirectorN/AN/A1974
Ms. Zhang QianVP & Board Sec.N/AN/A1963
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.

Corporate Governance

Chimin Health Management Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.